Vertex Pharmaceuticals Incorporated VRTX
NASDAQ · United States · Health Technology
$522.81-3.92 (-0.74%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-03 | 4.73 | 4.74 | -0.2% | $3.33B | +3.2% | +0.3%$477.10→$478.71 |
| Q1 2026 | 2026-05-04 | 4.47 | 4.31 | +3.7% | — | — | +0.1%$423.92→$424.36 |
| Q4 2025 | 2026-02-12 | 5.03 | 5.15 | -2.3% | — | — | +6.6%$461.24→$491.47 |
| Q3 2025 | 2025-11-03 | 4.80 | 4.58 | +4.8% | — | — | -0.9%$425.57→$421.67 |
| Q2 2025 | 2025-08-04 | 4.52 | 4.25 | +6.4% | — | — | — |
| Q1 2025 | 2025-05-05 | 4.06 | 4.29 | -5.4% | — | — | — |
| Q4 2024 | 2025-02-10 | 3.98 | 4.02 | -1.0% | — | — | — |
| Q3 2024 | 2024-11-04 | 4.38 | 4.13 | +6.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.